That is essential, because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be effective. To put it simply, we need to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (artificial intelligence). However now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. This was an advancement nearly nobody noticed. However it's going to have profound ramifications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of financial investment opportunities in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (genetic sequencer stock jeff brown). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back possibly substantially before going greater - jeff brown stock predictions 2021. I've been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly educating readers. But that's not the big question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. united states. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are so numerous fantastic private companies on the edge of striking the general public markets And I have actually been dealing with a brand-new method for you to invest even prior to these business go public.
This chance has been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our typical beat (jeff brown 2021 stock picks). And when it comes to tech investing, we leave it to the experts. The good news is, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we understand (jeff brown 1 biotech). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big picture and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid development and producing incredible opportunities for investors. I desire to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown top stock pick 2021. However in spite of what many readers may believe, this is a trend that's just starting. Even though the COVID-19 pandemic interrupted supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown 2020 predictions). Losing two months of production and sales actually affects the number of 5G gadgets are offered in the calendar year. When you consider all of that, selling 250 million units is exceptional. More importantly, the delays triggered by the pandemic created a load of suppressed need. And that need is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown top stock pick 2021. And that's not my only 5G prediction When I have actually spoken about 5G in the past, I've explained its 3 different phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Phase 3, 5G services start to be offered (tech stocks). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage Three by this summertime. This starts something of a virtuous cycle: Many individuals don't really care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment chances moving forward will be huge. Stepping far from 5G, the next important technology I anticipate in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not operate properly. CRISPR utilizes a similar idea but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And during that time, there were truly only 3 business operating in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering amazing returns. This entire industry is effectively a greenfield chance.
There's room for many companies to exist in this space. second wave. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can properly forecast the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is essential because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has been an experimental procedure. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug therapies produced utilizing this technology. This was among those breakthroughs that almost no one noticed. But it's going to have profound implications for treating illness. And, of course, there will be lots of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back possibly substantially prior to going higher. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever released was on bitcoin - exponential tech investor. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown genome sequencing. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details is up to date since February 2021, however we might not individually validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to select winning innovation stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an exceptional perspective on the market. He's always on the hunt for brand-new opportunities, and he shares a number of his finest picks in the Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he effectively forecasted a few of the biggest financial events of the past twenty years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it best every time, but Jeff Brown's accurate predictions have actually made him legions of devoted followers. That states a lot about his ability. The Near Future Report is released by Brownstone Research study, a prominent financial research publisher. Brownstone Research offers a number of research services with a broad variety of specializations - biotech stock.
The business is also connected with Bonner & Partners, another well-respected research publisher - biotech stocks. On its website, Brownstone states its mission is to supply retail financiers with professional-grade research study: "For too long, the very best investment research has actually not been offered to private investors. It has actually been typically reserved for investment banks, hedge funds, private equity, and high-net-worth customers. last week. The mission of Brownstone Research is to make that kind of exclusive research readily available to any financiers seeking to gain an edge in the marketplaces. The objective is simple to deliver unique and rewarding investment research study discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise functions as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you know even a bit about the market, you understand that he has a credibility as a King Midas of sorts. tech predictions. Whatever he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown thinks S.A.V. jeff brown biotech picks. might be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying two innovative innovations: expert system and electric cars and trucks. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the automotive industry's Holy Grail. As you know, electric vehicles and self-driving automobile stocks have actually been huge this year, however the Wall Street device has actually been huge on hype without much tangible outcome. Despite an extreme boost in competitors over the previous couple of years, Brown still thinks Musk has the very best chance of putting everything together.
tech might be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transport. Basically, this technology would enable you to rent your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You merely get out of the automobile and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a hefty chunk of the earnings. It sounds crazy, however it might be closed than you think.